Toreforant

JNJ-38518168 · Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Toreforant, covering 2017-07-07 to 2017-07-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis [Phase 2]

See pricing